AFRICA – A reported 1,000 kids in Africa die of Malaria every day.
Pretty soon, that number could be reduced by almost half. That’s the result of a clinical trial by British drug company GlaxoSmithKline.
The vaccine was given to kids in Africa ages five months to 17 months, and it proved to be a big breakthrough.
David Kaslow, Director of the PATH Malaria Vaccine Initiative, said, “This translates into really significantly reducing the pain and suffering because malaria continues to be a huge disease burden.”
Their work is far from over, but saving nearly 500 lives a day is a darn good start.